Clinical Trial Update: Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.

View source ↗

Summary

This clinical trial update evaluates intravenous laronidase pharmacokinetics before and after hematopoietic cell transplantation in patients with Mucopolysaccha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type

Drugs mentioned

• Aldurazyme (Laronidase)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Hematopoietic Cell Transplantation, Mucopolysaccharidosis Type I | Status: ACTIVE_NOT_RECRUITING